BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34921158)

  • 1. Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis.
    Lee BY; Hogg EKJ; Below CR; Kononov A; Blanco-Gomez A; Heider F; Xu J; Hutton C; Zhang X; Scheidt T; Beattie K; Lamarca A; McNamara M; Valle JW; Jørgensen C
    Nat Commun; 2021 Dec; 12(1):7336. PubMed ID: 34921158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer.
    Smigiel JM; Parameswaran N; Jackson MW
    Mol Cancer Res; 2017 Apr; 15(4):478-488. PubMed ID: 28053127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
    Zhang A; Qian Y; Ye Z; Chen H; Xie H; Zhou L; Shen Y; Zheng S
    Cancer Med; 2017 Feb; 6(2):463-470. PubMed ID: 28097809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
    Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA
    FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
    Yu Z; Li Z; Wang C; Pan T; Chang X; Wang X; Zhou Q; Wu X; Li J; Zhang J; Liu B; Zhu Z; Su L
    Gastric Cancer; 2019 Sep; 22(5):955-966. PubMed ID: 30778797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
    Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
    J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
    Araujo AM; Abaurrea A; Azcoaga P; López-Velazco JI; Manzano S; Rodriguez J; Rezola R; Egia-Mendikute L; Valdés-Mora F; Flores JM; Jenkins L; Pulido L; Osorio-Querejeta I; Fernández-Nogueira P; Ferrari N; Viera C; Martín-Martín N; Tzankov A; Eppenberger-Castori S; Alvarez-Lopez I; Urruticoechea A; Bragado P; Coleman N; Palazón A; Carracedo A; Gallego-Ortega D; Calvo F; Isacke CM; Caffarel MM; Lawrie CH
    J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35192545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth.
    Geethadevi A; Nair A; Parashar D; Ku Z; Xiong W; Deng H; Li Y; George J; McAllister DM; Sun Y; Kadamberi IP; Gupta P; Dwinell MB; Bradley WH; Rader JS; Rui H; Schwabe RF; Zhang N; Pradeep S; An Z; Chaluvally-Raghavan P
    Cancer Res; 2021 Oct; 81(20):5336-5352. PubMed ID: 34380633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin-M and OSM-Receptor Feed-Forward Activation of MAPK Induces Separable Stem-like and Mesenchymal Programs.
    Polak KL; Tamagno I; Parameswaran N; Smigiel J; Chan ER; Yuan X; Rios B; Jackson MW
    Mol Cancer Res; 2023 Sep; 21(9):975-990. PubMed ID: 37310811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment.
    Li Y; Zheng Y; Xu S; Hu H; Peng L; Zhu J; Wu M
    Int Immunopharmacol; 2024 May; 132():111944. PubMed ID: 38581990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
    Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
    J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.
    Jakob L; Müller TA; Rassner M; Kleinfelder H; Veratti P; Mitschke J; Miething C; Oostendorp RAJ; Pfeifer D; Waterhouse M; Duyster J
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.
    Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL
    Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages.
    Samain R; Brunel A; Douché T; Fanjul M; Cassant-Sourdy S; Rochotte J; Cros J; Neuzillet C; Raffenne J; Duluc C; Perraud A; Nigri J; Gigoux V; Bieche I; Ponzo M; Carpentier G; Cascone I; Tomasini R; Schmid HA; Mathonnet M; Nicolle R; Bousquet MP; Martineau Y; Pyronnet S; Jean C; Bousquet C
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1405-1436. PubMed ID: 33482394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
    FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.
    Seifert L; Werba G; Tiwari S; Giao Ly NN; Alothman S; Alqunaibit D; Avanzi A; Barilla R; Daley D; Greco SH; Torres-Hernandez A; Pergamo M; Ochi A; Zambirinis CP; Pansari M; Rendon M; Tippens D; Hundeyin M; Mani VR; Hajdu C; Engle D; Miller G
    Nature; 2016 Apr; 532(7598):245-9. PubMed ID: 27049944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin M and its receptors mRNA regulation in bovine granulosa and luteal cells.
    Martins KR; Haas CS; Ferst JG; Rovani MT; Goetten ALF; Duggavathi R; Bordignon V; Portela VVM; Ferreira R; Gonçalves PBD; Gasperin BG; Lucia T
    Theriogenology; 2019 Feb; 125():324-330. PubMed ID: 30504073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.
    Nallasamy P; Nimmakayala RK; Karmakar S; Leon F; Seshacharyulu P; Lakshmanan I; Rachagani S; Mallya K; Zhang C; Ly QP; Myers MS; Josh L; Grabow CE; Gautam SK; Kumar S; Lele SM; Jain M; Batra SK; Ponnusamy MP
    Gastroenterology; 2021 Dec; 161(6):1998-2013.e7. PubMed ID: 34418441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.